Of Counsel Kyle Faget published the article “Clinical Decision Support Software: FDA’s Risk-based Approach,” in Issue 47 of Asian Hospital and Healthcare Management.
The article focuses on the importance of Clinical Decision Support (CDS) software to healthcare professionals, allowing them to use data to enhance the care they provide. It also looks at how the U.S. Food & Drug Administration (FDA) is providing guidance to provide clarity on the scope of the FDA’s oversight of this type of software.
You can read the full article on page 52 of the issue here.
People
Related News
03 May 2024
In the News
Jeff Symons’ Move to Foley Featured in Press
Foley & Lardner LLP partner Jeff Symons is featured in legal press for his recent arrival to the firm
03 May 2024
In the News
Nathaniel Lacktman on Healthleaders Podcast– ‘We’re seeing maturity in the telemedicine market’
Foley & Lardner LLP partner Nathaniel Lacktman discussed the upcoming American Telemedicine Association’s annual conference, new developments in telemedicine and digital health, the regulatory context, and the prospects for the industry’s future
02 May 2024
In the News
Jennifer Hennessy on American Privacy Rights Act – ‘This law does have teeth’
Foley & Lardner LLP partner Jennifer Hennessy assesses the prospects of what could be the first federal data privacy law passed in the United States